NCT01475734View on ClinicalTrials.gov

Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL

albiglutide

subcutaneous injection

BIOLOGICAL

placebo

subcutaneous injection

Trial Locations (1)

91911

GSK Investigational Site, Chula Vista

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01475734 - Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter